Cytokinetics, Inc. (NASDAQ: CYTK) is engaged as a late-stage biopharmaceutical company, which is focused on the research, development, and commercialization ...
Not all analysts and their respective opinions are created equal. Reputation and track record can be defining features that elevate ...
In the table below are the Food and Drug Administration (FDA) announcements scheduled for February 2020. Company Name Announcement Date ...
Vermillion, Inc. (NASDAQ: VRML) is engaged in the discovery, development, and commercialization of diagnostic and bio-analytical solutions for women’s health ...
Axsome Therapeutics, Inc. (NASDAQ: AXSM) operates as a clinical-stage biopharmaceutical company that is focused on developing treatments for central nervous ...
Agenus, Inc. (NASDAQ: AGEN) is a clinical-stage immuno-oncology company focused on the development of therapies that utilize the body's immune ...
